Green Thumb Industries (GTBIF) Accounts Payables (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Accounts Payables came in at $20.1 million in Q1 2026, up 4.02% YoY from $19.3 million in Q1 2025, and down 18.25% on a QoQ basis from $24.6 million in Q4 2025.
Green Thumb Industries (GTBIF) Accounts Payables (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Accounts Payables data on file, last reported at $20.1 million in Q1 2026.
- Quarterly Accounts Payables rose 4.02% year-over-year to $20.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.1 million (up 4.02% YoY) and the FY2025 annual result came in at $24.6 million, down 0.8% from the prior year.
- Accounts Payables fell to $20.1 million in Q1 2026, from $24.6 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $29.4 million in Q2 2024 to a low of $14.1 million in Q3 2022.
- A 5-year average of $22.4 million and a median of $22.5 million in 2023 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables soared 153.96% — and 2025, when it tumbled 30.65%.
- Tracing GTBIF's Accounts Payables over 5 years: stood at $18.4 million in 2022, then soared by 32.96% to $24.5 million in 2023, then rose by 1.11% to $24.8 million in 2024, then retreated by 0.8% to $24.6 million in 2025, then declined by 18.25% to $20.1 million in 2026.
- The last three Accounts Payables figures came in at $20.1 million (Q1 2026), $24.6 million (Q4 2025), and $24.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Green Thumb Industries | 1.69 Bn | 1.41 Bn | 137.87 Mn | 17.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.12 Mn |
| Mar 31, 2026 | 20.08 Mn |
| Dec 31, 2025 | 24.57 Mn |
| Sep 30, 2025 | 24.54 Mn |
| Jun 30, 2025 | 22.41 Mn |
| Mar 31, 2025 | 19.31 Mn |
| Dec 31, 2024 | 24.77 Mn |
| Sep 30, 2024 | 19.85 Mn |
| Jun 30, 2024 | 29.43 Mn |
| Mar 31, 2024 | 27.84 Mn |
| Dec 31, 2023 | 24.50 Mn |
| Sep 30, 2023 | 22.51 Mn |
| Jun 30, 2023 | 27.49 Mn |
| Mar 31, 2023 | 16.91 Mn |
| Dec 31, 2022 | 18.42 Mn |
| Sep 30, 2022 | 14.08 Mn |
| Jun 30, 2022 | 19.88 Mn |
| Mar 31, 2022 | 23.65 Mn |
| Dec 31, 2021 | 14.09 Mn |
| Sep 30, 2021 | 9.81 Mn |